0001562180-21-001243.txt : 20210218
0001562180-21-001243.hdr.sgml : 20210218
20210218081731
ACCESSION NUMBER: 0001562180-21-001243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZUMWALT LEANNE M
CENTRAL INDEX KEY: 0001204946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 21647720
MAIL ADDRESS:
STREET 1: C/O THE ADVISORY BOARD CO WATERGATGE
STREET 2: 600 NEW HAMPSHIRE AVE NW
CITY: WASHINGTON
STATE: DC
ZIP: 20037
FORMER NAME:
FORMER CONFORMED NAME: ZURNWALT LEANNE M
DATE OF NAME CHANGE: 20021109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-02-16
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001204946
ZUMWALT LEANNE M
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST ST.
CAMBRIDGE
MA
02142
true
false
false
false
Stock Option (Right to buy)
4.87
2021-02-16
4
A
false
80200.00
0.00
A
2031-02-16
Common Stock
80200.00
80200.00
D
The options will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter.
/s/ Andrea J. Paul, attorney-in-fact for LeAnne M. Zumwalt
2021-02-18